Phase I/II trial of YHI-1003 plus Capecitabine
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: investigational material(s) Generic name etc : YHI-1003 INN of investigational material : Perifosine Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : oral Primary outcome(s): safety CTCAE v4.0 Study Design: open-label, multicenter trial
创建时间：
2011-12-15
